Literature DB >> 11049981

Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.

K Brasel1, T De Smedt, J L Smith, C R Maliszewski.   

Abstract

Murine dendritic cells (DCs) can be classified into at least 2 subsets, "myeloid-related" (CD11b(bright), CD8alpha(-)) and "lymphoid-related" (CD11b(dull), CD8alpha(+)), but the absolute relationship between the 2 remains unclear. Methods of generating DCs from bone marrow (BM) precursors in vitro typically employ granulocyte-macrophage colony-stimulating factor (GM-CSF) as the principal growth factor, and the resultant DCs exhibit a myeloidlike phenotype. Here we describe a flt3-ligand (FL)-dependent BM culture system that generated DCs with more diverse phenotypic characteristics. Murine BM cells cultured at high density in recombinant human FL for 9 days developed into small lymphoid-sized cells, most of which expressed CD11c, CD86, and major histocompatibility complex (MHC) class II. The CD11c(+) population could be divided into 2 populations on the basis of the level of expression of CD11b, which may represent the putative myeloid- and lymphoid-related subsets. The FL in vitro-derived DCs, when treated with interferon-alpha or lipopolysaccharide during the final 24 hours of culture, expressed an activated phenotype that included up-regulation of MHC class II, CD1d, CD8alpha, CD80, CD86, and CD40. The FL-derived DCs also exhibited potent antigen-processing and antigen-presenting capacity. Neutralizing anti-interleukin-6 (IL-6) antibody, but not anti-GM-CSF, significantly reduced the number of DCs generated in vitro with FL, suggesting that IL-6 has a role in the development of DCs from BM precursors. Stem cell factor, which exhibits some of the same bioactivities as FL, was unable to replace FL to promote DC development in vitro. This culture system will facilitate detailed analysis of murine DC development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049981

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  137 in total

1.  Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset.

Authors:  Uma Sriram; Linda Varghese; Heather L Bennett; Neelakshi R Jog; Debra K Shivers; Yue Ning; Edward M Behrens; Roberto Caricchio; Stefania Gallucci
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

3.  Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells.

Authors:  Kenya Honda; Tatsuaki Mizutani; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

4.  CCAAT/enhancer binding protein-δ expression by dendritic cells regulates CNS autoimmune inflammatory disease.

Authors:  Vicky W W Tsai; Mohammad G Mohammad; Ornella Tolhurst; Samuel N Breit; Paul E Sawchenko; David A Brown
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

Review 5.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

6.  Dendritic cells are early responders to retinal injury.

Authors:  Ute Lehmann; Neal D Heuss; Scott W McPherson; Heidi Roehrich; Dale S Gregerson
Journal:  Neurobiol Dis       Date:  2010-05-23       Impact factor: 5.996

7.  Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis.

Authors:  Timothy M Johanson; Ashleigh A Keown; Marek Cmero; Janet H C Yeo; Amit Kumar; Andrew M Lew; Yifan Zhan; Mark M W Chong
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

Review 8.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

9.  Consequences of AhR activation in steady-state dendritic cells.

Authors:  Tom Simones; David M Shepherd
Journal:  Toxicol Sci       Date:  2010-11-19       Impact factor: 4.849

10.  In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development.

Authors:  Panagiotis Tsapogas; Lee Kim Swee; Anja Nusser; Natko Nuber; Matthias Kreuzaler; Giuseppina Capoferri; Hannie Rolink; Rhodri Ceredig; Antonius Rolink
Journal:  Haematologica       Date:  2014-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.